Department of Neurology, the University hospital of North Norway, Tromsø, Norway.
Headache. 2011 Feb;51(2):300-5. doi: 10.1111/j.1526-4610.2010.01820.x.
Remission of hemicrania continua (HC) and transformation from HC to chronic paroxysmal hemicrania (CPH) are unusual. We report a patient with left-sided HC who, after a period of remission, presented as CPH. The continuous HC headache disappeared completely after initiating treatment with cyclooxygenase (COX)-2 inhibitor, but reappeared on the same side after 14 months remission with paroxysmal, frequent, intense and short-lasting headache attacks accompanied by ipsilateral cranial autonomic symptoms. This happened shortly after the treatment was discontinued because of withdrawal of the COX-2 inhibitor from the market. The response to indomethacin was prompt, and the patient became completely free from her paroxysmal headache with a dose of 50 mg 2 times daily. This case questions a possible modification effect on the course of HC by use of COX-2 inhibitor, as well as further supporting that some aspects of the pathophysiology of HC may resemble those of CPH, and may argue for common biological mechanisms in HC and CPH.
丛集性头痛(HC)缓解和向慢性阵发性头痛(CPH)转变并不常见。我们报告了一例左侧 HC 患者,在缓解期后表现为 CPH。在开始使用环氧化酶(COX)-2 抑制剂治疗后,持续的 HC 头痛完全消失,但在缓解 14 个月后,同侧出现阵发性、频繁、剧烈且持续时间短的头痛发作,并伴有同侧颅自主症状。这是在 COX-2 抑制剂因撤出市场而停药后不久发生的。吲哚美辛反应迅速,患者每日 2 次、每次 50mg 的剂量完全摆脱了阵发性头痛。该病例质疑 COX-2 抑制剂的使用可能会改变 HC 的病程,并且进一步支持 HC 的某些病理生理学方面可能类似于 CPH,并且可能支持 HC 和 CPH 之间存在共同的生物学机制。